NDC 82584-609

ZIOPTAN

Tafluprost

ZIOPTAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Thea Pharma Inc.. The primary component is Tafluprost.

Product ID82584-609_ec1dfc7a-46bb-7414-e053-2995a90a9929
NDC82584-609
Product TypeHuman Prescription Drug
Proprietary NameZIOPTAN
Generic NameTafluprost
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2022-10-28
Marketing CategoryNDA /
Application NumberNDA202514
Labeler NameThea Pharma Inc.
Substance NameTAFLUPROST
Active Ingredient Strength0 mg/mL
Pharm ClassesIncreased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 82584-609-30

3 POUCH in 1 CARTON (82584-609-30) > 10 VIAL, SINGLE-USE in 1 POUCH (82584-609-01) > .3 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2022-10-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ZIOPTAN" or generic name "Tafluprost"

NDCBrand NameGeneric Name
17478-609ZIOPTANtafluprost
82584-609ZIOPTANTafluprost
0781-6184TafluprostTafluprost
65302-062TafluprostTafluprost
66993-429Tafluprost Ophthalmictafluprost

Trademark Results [ZIOPTAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZIOPTAN
ZIOPTAN
85091319 4161745 Live/Registered
Merck Sharp & Dohme Corp.
2010-07-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.